NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 41 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $10 | -99.9% | 21,188 | 0.0% | 0.00% | – |
| Q3 2022 | $13,000 | -7.1% | 21,188 | +175.4% | 0.00% | – |
| Q1 2022 | $14,000 | -87.5% | 7,693 | -67.1% | 0.00% | – |
| Q4 2021 | $112,000 | -57.9% | 23,405 | +46.0% | 0.00% | -100.0% |
| Q2 2020 | $266,000 | -91.6% | 16,033 | -94.2% | 0.00% | -94.4% |
| Q1 2020 | $3,160,000 | -46.3% | 277,633 | -41.9% | 0.02% | -33.3% |
| Q4 2019 | $5,885,000 | +238.6% | 477,740 | -21.6% | 0.03% | +285.7% |
| Q3 2019 | $1,738,000 | – | 609,651 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 2,291,133 | $1,166,187 | 1.01% |
| Privium Fund Management (UK) Ltd | 117,200 | $59,655 | 0.04% |
| Redmile Group, LLC | 1,850,566 | $941,938 | 0.04% |
| Baker Brothers Advisors | 3,821,740 | $1,945,266 | 0.01% |
| Kynam Capital Management, LP | 120,764 | $61,469 | 0.01% |
| Sio Capital Management, LLC | 38,312 | $19,501 | 0.01% |
| SIMON QUICK ADVISORS, LLC | 46,856 | $23,850 | 0.00% |
| Tri Locum Partners LP | 10,248 | $5,000 | 0.00% |
| Endurance Wealth Management, Inc. | 20,000 | $10 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 75,000 | $38,175 | 0.00% |